XML 48 R38.htm IDEA: XBRL DOCUMENT
v3.23.3

(LOSS) EARNINGS PER SHARE (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Earnings Per Share [Abstract] |
Schedule of calculation of (loss) earnings per share | (Loss) earnings per share attributable to Bausch Health Companies Inc. is calculated as follows:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
(in millions, except per share amounts) | 2023 |  | 2022 |  | 2023 |  | 2022
Net (loss) income attributable to Bausch Health Companies Inc. | $ | (378) |  |  | $ | 399 |  |  | $ | (553) |  |  | $ | 185 |
Basic weighted-average common shares outstanding | 365.4 |  |  | 362.5 |  |  | 364.5 |  |  | 361.8 |
Diluted effect of stock options and RSUs | — |  |  | 0.9 |  |  | — |  |  | 1.9 |
Diluted weighted-average common shares outstanding | $ | 365.4 |  |  | $ | 363.4 |  |  | $ | 364.5 |  |  | $ | 363.7 |
(Loss) earnings per share attributable to Bausch Health Companies Inc. |  |  |  |  |  |  |
Basic | $ | (1.03) |  |  | $ | 1.10 |  |  | $ | (1.52) |  |  | $ | 0.51 |
Diluted | $ | (1.03) |  |  | $ | 1.10 |  |  | $ | (1.52) |  |  | $ | 0.51 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration